1.
Br J Anaesth
; 127(3): e111-e113, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1260672
Subject(s)
COVID-19/therapy , Milrinone/therapeutic use , Oxygen Inhalation Therapy/methods , Respiration, Artificial/methods , Vasodilator Agents/therapeutic use , Administration, Inhalation , Aged , Female , Humans , Hypertension, Pulmonary , Male , Middle Aged , Milrinone/administration & dosage , Respiratory Dead Space , Vasodilator Agents/administration & dosage
2.
Cardiol Young
; 31(3): 485-487, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-1131993
ABSTRACT
A four- and a half-month-old girl with severe dilated cardiomyopathy due to neonatal enterovirus myocarditis, treated with diuretics and milrinone for the past 4 months, was infected with SARS-CoV-2. The disease course was characterised by high fever and gastrointestinal symptoms. Cardiac function, as measured by echocardiography, remained stable. The treatment focused on maintaining a normal heart rate and a stable fluid balance. In children with severe underlying cardiac disease, even a mild SARS-CoV-2 infection can require close monitoring and compound treatment.